L3VLUP
ProSign in

EXEL in the 13F filings

Exelixis Inc · CUSIP 30161Q104

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
14 Feb 2024
latest of these filings; the earliest 8 Feb 2024
Managers listing it
13
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 10 listed it in both
Shares listed
50,583,090
combined, among listed positions
Reported value
$1.2bn
combined, at the quarter end

Among the 93 comparable managers: 6 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing EXEL in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

13 of 13 holders

ActionFiling
Farallon Capital Management LLC26,634,500$639m2.92%Added+774,50014 Feb 2024 (the filing on sec.gov)
Renaissance Technologies LLC15,615,716$375m0.58%Added+398,80013 Feb 2024 (the filing on sec.gov)
AQR Capital Management LLC2,178,705$52m0.10%Added+162,86714 Feb 2024 (the filing on sec.gov)
Two Sigma Advisers LP1,840,490$44m0.10%Trimmed-373,70014 Feb 2024 (the filing on sec.gov)
Acadian Asset Management LLC1,772,177$42m0.16%Trimmed-185,67113 Feb 2024 (the filing on sec.gov)
Woodline Partners LP987,094$24m0.26%Held014 Feb 2024 (the filing on sec.gov)
Man Group PLC761,377$18m0.05%Addedn.a.14 Feb 2024 (the filing on sec.gov)
Voloridge Investment Management LLC419,963$10munder 0.1%Addedn.a.14 Feb 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP186,051$4.5munder 0.1%Trimmed-356,16014 Feb 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP115,000$2.8munder 0.1%Trimmed-5,00014 Feb 2024 (the filing on sec.gov)
First Eagle Investment Management LLC25,195$604kunder 0.1%Held08 Feb 2024 (the filing on sec.gov)
Caxton Associates LLP24,534$589kunder 0.1%Newnew14 Feb 2024 (the filing on sec.gov)
Winton Group Ltd22,288$535kunder 0.1%Trimmed-74512 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
12 in Q3 2024 to 15 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
EXEL by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$200mn.a.n.a.
Q3 20134$267mn.a.n.a.
Q4 20133$283mn.a.n.a.
Q1 20144$3.6mn.a.n.a.
Q4 20141$3.5mn.a.n.a.
Q3 20151$138mn.a.n.a.
Q4 20154$185mn.a.n.a.
Q1 20161$905kn.a.n.a.
Q2 20167$108mn.a.n.a.
Q3 201612$909mn.a.n.a.
Q4 201614$1.3bnn.a.n.a.
Q1 201711$1.6bnn.a.n.a.
Q2 201721$1.9bnn.a.n.a.
Q3 201715$1.9bnn.a.n.a.
Q4 201715$2.2bnn.a.n.a.
Q1 201813$1.4bnn.a.n.a.
Q2 20189$902mn.a.n.a.
Q3 20187$619mn.a.n.a.
Q4 201810$818mn.a.n.a.
Q1 20197$1.2bnn.a.n.a.
Q2 20195$1.0bnn.a.n.a.
Q3 20197$533mn.a.n.a.
Q4 201910$659mn.a.n.a.
Q1 202012$924mn.a.n.a.
Q2 202018$1.5bnn.a.n.a.
Q3 202018$1.8bnn.a.n.a.
Q4 202011$1.2bnn.a.n.a.
Q1 202113$1.3bnn.a.n.a.
Q2 202110$976mn.a.n.a.
Q3 202113$1.1bnn.a.n.a.
Q4 20219$922mn.a.n.a.
Q1 202210$1.2bnn.a.n.a.
Q2 202212$1.4bnn.a.n.a.
Q3 202211$630mn.a.n.a.
Q4 202211$714mn.a.n.a.
Q1 202312$1.1bnn.a.n.a.
Q2 202310$976mn.a.n.a.
Q3 202312$1.1bnn.a.n.a.
Q4 202313$1.2bn66
Q1 202411$1.2bn64
Q2 202411$1.1bn73
Q3 202412$1.3bn84
Q4 202413$1.8bn76
Q1 202513$2.0bn75
Q2 202513$2.1bn68
Q3 20259$2.1bn54
Q4 202511$2.3bn1916
Q1 202612$2.3bn1420
Q2 202615$3.1bn2210

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

EXEL and GILD →EXEL and AMGN →EXEL and ARGX →Choose a stock to compare with EXEL →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own EXEL, latest filings →Back to the 13F Explorer →